Zovestus Global advises and acquires companies and brands.
Our consultants based in Europe and China accelerate business.
Often they are found helping Chinese companies in Europe and European companies in China
They are skilled at start-ups, creating new brands, boosting business development, reducing risk, due diligence reports, timely new product development, finding new customers and channels, facilitating new market entry, and opening-up new international markets.
Its emerging international pharmaceutical and healthcare company acquires control positions in businesses that may have become non-core to the vendor. They may face restructuring or there are benefits from consolidation, internationalisation and other performance improvement opportunities.
Zovestus has the capacity and flexibility to invest from €1m to €75 million into these acquisitions utilising its own capital and leveraging proprietary co-investment partnerships with several leading financial institutions
Recent consulting projects include sourcing and developing new nutraceutical products from Europe for China. Establishing a sales channel in China for an established USA prescription medicine. Developing an internationalisation strategy for a niche UK based generics company. Providing European BD support for a Chinese aesthetics company. Advising PE funds in London, Shanghai and Johannesburg on European specialty pharma. acquisitions.
For Further information
UK Office
Tel: +44 (0)7795 404034
China Office
Tel: +86 1852 108 6702